news

US government takes steps to reduce drug costs

8
SHARES

New regulations and legislations are being formed in the US to combat healthcare costs, including drug prices.

The US government is taking several steps to reduce the cost of healthcare in the country, including pushing for new legislation.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

President Donald Trump has announced that his administration is compiling an executive order to decrease US drug prices. This new regulation would ensure that medicine costs matched the lowest in the world.

The president has accused pharmaceutical companies of taking advantage of the system for a long time.

“We’re working on a favoured nations law where we pay whatever the lowest nation’s price is,” said Trump. “As you know, for years and years other nations paid less for drugs than we do, sometimes by 60 percent, 70 percent,” he said.

This coincides with different parties from the Senate and House of the US government agreeing to push for more affordable healthcare in the country, including high prices for medicines.

“Obviously we will continue to have significant disagreements on… Obamacare,” said Republican Senator Lamar Alexander. “What we’ve done is shift our focus to the larger topic, or the different topic, of reducing health care costs.”

Other new legislation will become effective in the US later this month which will require pharmaceutical companies to disclose the price of their drugs during television advertisements, to improve transparency.

Share via
Share via